Literature DB >> 1327728

Intracranial and intraspinal dissemination of an ACTH-secreting pituitary tumor.

H Kouhara1, T Tatekawa, M Koga, S Hiraga, N Arita, H Mori, B Sato.   

Abstract

A case of a 29-year-old man with an ACTH-producing pituitary tumor disseminated into the subarachnoid space is described. After total adrenalectomy for Cushing's disease at the age of 15, Nelson's syndrome developed. Transsphenoidal adenomectomy at 17 and 21 years of age, pituitary irradiation and medical therapies with sodium valproate, baclofen and bromocriptine failed to lower his plasma ACTH level. Multiple intracranial and intraspinal tumors associated with the symptoms of left hemiparesis developed. The removal of a tumor grown at the level of C1-3 was performed with successful palliation of his symptoms. Histologically, the tumor cells showed sinusoidal, papillary and diffuse patterns with a preponderance of the former over the latter two, although the papillary pattern predominated in the primary pituitary tumor. Immunohistochemical analysis demonstrated most cells to be positive for ACTH in the metastatic tumor as well as the primary adenoma. The clinical significance of his course is discussed with a review of 11 reported cases with metastatic ACTH-producing pituitary tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327728     DOI: 10.1507/endocrj1954.39.177

Source DB:  PubMed          Journal:  Endocrinol Jpn        ISSN: 0013-7219


  9 in total

1.  Drop metastasis of adrenocorticotropic hormone-producing pituitary carcinoma to the cauda equina.

Authors:  Kenichi Takeuchi; Yoko Hagiwara; Koichi Kanaya; Keiji Wada; Masahiro Shiba; Yoshiharu Kato
Journal:  Asian Spine J       Date:  2014-10-18

Review 2.  Corticotroph pituitary carcinoma: case report and literature review.

Authors:  D J Holthouse; P D Robbins; R Kahler; N Knuckey; P Pullan
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 3.  Malignant pituitary corticotroph adenomas: report of two cases and a comprehensive review of the literature.

Authors:  Agatha A van der Klaauw; Tina Kienitz; Christian J Strasburger; Johannes W A Smit; Johannes A Romijn
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

4.  Possible role of a radiation-induced p53 mutation in a Nelson's syndrome patient with a fatal outcome.

Authors:  Emilia Modolo Pinto; Sheila A C Siqueira; Priscilla Cukier; Maria C B V Fragoso; Chin Jia Lin; Berenice Bilharinho de Mendonca
Journal:  Pituitary       Date:  2011-12       Impact factor: 4.107

5.  Pituitary Carcinomas.

Authors:  Wolfgang Saeger; Dorothee Lubke
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

6.  A case of corticotroph carcinoma that caused multiple cranial nerve palsies, destructive petrosal bone invasion, and liver metastasis.

Authors:  Masami Ono; Nobuhiro Miki; Kosaku Amano; Motohiro Hayashi; Takakazu Kawamata; Toshiro Seki; Kazue Takano; Satosi Katagiri; Masakazu Yamamoto; Toshio Nishikawa; Osami Kubo; Toshiaki Sano; Tomokatsu Hori; Yoshikazu Okada
Journal:  Endocr Pathol       Date:  2011-03       Impact factor: 3.943

7.  Long-term follow-up of growth hormone-producing pituitary carcinoma with multiple spinal metastases following multiple surgeries: case report.

Authors:  Toshihide Tanaka; Naoki Kato; Ken Aoki; Mitsuyoshi Watanabe; Takao Arai; Yuzuru Hasegawa; Toshiaki Abe
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-09-27       Impact factor: 1.742

8.  lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes.

Authors:  Xuejian Wang; Xiangdong Li; Zhifeng Wang
Journal:  Oncol Rep       Date:  2021-03-02       Impact factor: 3.906

9.  Multiple intracranial and spinal metastases from a nonfunctioning pituitary adenoma following multiple surgeries: an illustrative case with 16 years of follow-up.

Authors:  Jun Wang; Er-Meng Ma; Peng-Fei Wu; Bo Qiu And; Yun-Jie Wang
Journal:  World J Surg Oncol       Date:  2014-12-12       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.